AtherosclerosisAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantArteriosclerosisApolipoproteins ECarotid Artery DiseasesCombined Modality TherapyAntineoplastic AgentsCisplatinTreatment OutcomeDiet, AtherogenicCyclophosphamideDoxorubicinAortic DiseasesAortaCoronary Artery DiseaseCarotid ArteriesRisk FactorsTunica IntimaTunica MediaNeoadjuvant TherapyCholesterolDisease-Free SurvivalPrognosisPlaque, AtheroscleroticEtoposideBreast NeoplasmsSurvival AnalysisNeoplasm StagingDisease ProgressionSurvival RateLipoproteins, LDLIntracranial ArteriosclerosisDrug Administration ScheduleMice, KnockoutReceptors, LDLLung NeoplasmsProspective StudiesMethotrexateTime FactorsFollow-Up StudiesLipidsCarotid Intima-Media ThicknessHypercholesterolemiaCarboplatinPaclitaxelCholesterol, DietaryMacrophagesFoam CellsMice, Inbred C57BLEndothelium, VascularInduction ChemotherapyVinblastineCarotid Artery, CommonCalcinosisDisease Models, AnimalNeoplasm Recurrence, LocalTaxoidsInflammationIfosfamideNeoplasmsDrug Resistance, NeoplasmLipoproteinsCoronary VesselsBiological MarkersBleomycinHyperlipidemiasDeoxycytidineOrganoplatinum CompoundsAntimetabolites, AntineoplasticAorta, ThoracicCzechoslovakiaAnthracyclinesAntineoplastic Agents, AlkylatingChlamydophila pneumoniaeCholesterol, HDLChemotherapy, Cancer, Regional PerfusionCytarabineMultivariate AnalysisSalvage TherapyCarcinoma, Non-Small-Cell LungPredictive Value of TestsDose-Response Relationship, DrugCholesterol, LDLOvarian NeoplasmsMuscle, Smooth, VascularNeoplasm MetastasisTriglyceridesClinical Trials as TopicTransplantation, AutologousCohort StudiesTesticular NeoplasmsVomitingAorta, AbdominalTomography, X-Ray ComputedNeutropeniaAdenocarcinomaNauseaLymphoma, Non-HodgkinRisk Assessment